CYCN Stock Analysis: Buy, Sell, or Hold?
CYCN - Cyclerion Therapeutics, Inc. Common Stock
$1.36
-0.01 (-0.73%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Mar 03, 2026
30d
Get Alerted When CYCN Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
3 traders called CYCN this week
67% bullish • 1 bearish
67% bullish • 1 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: CYCN is down 11.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: CYCN is down 11.7% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: CYCN is currently trading at $1.36, which is considered slightly low relative to its 30-day fair value range of $1.27 to $1.66.
Technical Outlook: Technically, CYCN is in a strong downtrend. The price is currently testing key support at $1.33. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+192.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, CYCN is in a strong downtrend. The price is currently testing key support at $1.33. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $4.00 (+192.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$1.27 -
$1.66
Company Quality Score
42/100
(HOLD)
Volume Confirmation
MODERATE
Confidence Score
77.4%
Protect Your Profits
Holding CYCN? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: Trading 192.0% below Wall St target ($4.00)
- WARNING: Recommendation downgraded due to -11.7% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$1.27 -
$1.66
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$1.33
Resistance Level
$1.69
Current Trend
Strong Downtrend
Fundamental Context
Wall Street Target
$4.00
(+192.0%)
Revenue Growth (YoY)
351.0%
Profit Margin
-77.0%
Last updated: January 31, 2026 1:09 PM ET
Data refreshes hourly during market hours. Next update: 2:09 PM
Data refreshes hourly during market hours. Next update: 2:09 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CYCN showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
SRPT
Sarepta Therapeutics Inc |
STRONG BUY
26 analysts |
$21 | 54 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
33 analysts |
$486 | 45 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$500 | 62 BUY |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$91 | 64 BUY |
|
REGN
Regeneron Pharmaceutical… |
STRONG BUY
25 analysts |
$830 | 52 HOLD |
Advanced CYCN Option Strategies
Professional options setups generated by AI based on today's CYCN price and gamma walls.
